Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Efficient use of open label extension data to support additional evidence of efficacy and disease modification hypotheses | Synapse
March 3, 2026
Efficient use of open label extension data to support additional evidence of efficacy and disease modification hypotheses
KH
Kent Hendrix
SH
Suzanne Hendrix
TetraLogic Pharmaceuticals (United States)
SD
Samuel P. Dickson
TetraLogic Pharmaceuticals (United States)
Puntos clave
Efficacy was further supported through careful analysis of open label extension data, enhancing treatment insights.
Key evidence identified from data analysis indicated significant outcomes related to disease modification over time.
The methodology involved utilizing open label extension data to explore hypotheses regarding efficacy and disease progression.
These findings may enable better therapeutic strategies, though confirmatory studies are warranted to substantiate evidence.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Hendrix et al. (Mon,) studied this question.
synapsesocial.com/papers/69a75edac6e9836116a29d2f
https://doi.org/https://doi.org/10.1016/j.jns.2025.124099